Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. (Q30369679)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

2

object named as

Richard J Webby

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Peggy A Lalor

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jane Morrow

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Denis Rusalov

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

David C Kaslow

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Alain Rolland

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Larry R Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

197

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1643-1652

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

A history of influenza

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Avian influenza virus (H5N1): a threat to human health.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Seasonal and pandemic influenza preparedness: science and countermeasures

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Three Indonesian clusters of H5N1 virus infection in 2005

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Vaccines for seasonal and pandemic influenza.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

The annual production cycle for influenza vaccine

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

DNA Immunization for Influenza Virus: Studies Using Hemagglutinin‐ and Nucleoprotein‐Expressing DNAs

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Characterization of the 1918 influenza virus polymerase genes

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

The origins of pandemic influenza--lessons from the 1918 virus.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

1 reference

https://api.crossref.org/works/10.1086%2F588431

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30369679&oldid=1596152695"